Accumulating studies showed that increased CDCA5 level was a diagnostic biomarker and risk factor for numerous cancers which could enhance the tumor cells' capability of proliferation and metastasis by oncogenic ERK5-AP-1 pathway [33, 34]. This evidence concerns the gene CDCA5 and cancer.